Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 10, 2020
Antithrombotic Effects of Combined PAR (Protease-Activated Receptor)-4 Antagonism and Factor Xa Inhibition
Mohammed N Meah, Jennifer Raftis, Simon J Wilson, et al.
Clinical and Translational Science
|
October 25, 2024
Absolute oral bioavailability of milvexian spray-dried dispersion formulation under fasted and fed conditions in healthy adult participants: An intravenous microtracer approach
Praneeth Jarugula, Sharif Soleman, Hyunmoon Back, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 13, 2024
Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration
Peter Chang, Vidya Perera, David H Salinger, et al.
Dermatology and Therapy
|
September 4, 2025
Efficacy and Safety of Zabedosertib, an Interleukin-1 Receptor-Associated Kinase 4 Inhibitor, in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase II Randomized Study
Stefan J Jodl, Margitta Worm, Frauke Friedrichs, et al.
Clinical Pharmacokinetics
|
February 9, 2020
Inability of Current Dosing to Achieve Carboplatin Therapeutic Targets in People with Advanced Non-Small Cell Lung Cancer: Impact of Systemic Inflammation on Carboplatin Exposure and Clinical Outcomes
Benjamin D W Harris, Viet Phan, Vidya Perera, et al.
Clinical Pharmacology and Therapeutics
|
April 30, 2025
Modeling and Simulation to Inform Apixaban Dosing in Pediatrics With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated With Asparaginase
Praneeth Jarugula, Toni Ajavon-Hartmann, Obinna Obianom, et al.
International Journal of Antimicrobial Agents
|
January 3, 2015
Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder
John G Y Chan, Anneliese S Tyne, Angel Pang, et al.
The Journal of Rheumatology
|
January 15, 2025
Association Between Abatacept Exposure Levels and Infection Occurrence in Patients With Rheumatoid Arthritis: Post Hoc Analysis of the AVERT-2 Study
Paul Emery, Roy Fleischmann, Robert Wong, et al.
Clinical Pharmacology and Therapeutics
|
June 24, 2025
Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart Disease
Antoinette Ajavon-Hartmann, Praneeth Jarugula, Hyunmoon Back, et al.
British Journal of Clinical Pharmacology
|
January 19, 2018
First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects
Vidya Perera, Joseph M Luettgen, Zhaoqing Wang, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 10, 2020
Antithrombotic Effects of Combined PAR (Protease-Activated Receptor)-4 Antagonism and Factor Xa Inhibition
Mohammed N Meah, Jennifer Raftis, Simon J Wilson, et al.
Clinical and Translational Science
|
October 25, 2024
Absolute oral bioavailability of milvexian spray-dried dispersion formulation under fasted and fed conditions in healthy adult participants: An intravenous microtracer approach
Praneeth Jarugula, Sharif Soleman, Hyunmoon Back, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
August 13, 2024
Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration
Peter Chang, Vidya Perera, David H Salinger, et al.
Dermatology and Therapy
|
September 4, 2025
Efficacy and Safety of Zabedosertib, an Interleukin-1 Receptor-Associated Kinase 4 Inhibitor, in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase II Randomized Study
Stefan J Jodl, Margitta Worm, Frauke Friedrichs, et al.
Clinical Pharmacokinetics
|
February 9, 2020
Inability of Current Dosing to Achieve Carboplatin Therapeutic Targets in People with Advanced Non-Small Cell Lung Cancer: Impact of Systemic Inflammation on Carboplatin Exposure and Clinical Outcomes
Benjamin D W Harris, Viet Phan, Vidya Perera, et al.
Clinical Pharmacology and Therapeutics
|
April 30, 2025
Modeling and Simulation to Inform Apixaban Dosing in Pediatrics With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated With Asparaginase
Praneeth Jarugula, Toni Ajavon-Hartmann, Obinna Obianom, et al.
International Journal of Antimicrobial Agents
|
January 3, 2015
Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder
John G Y Chan, Anneliese S Tyne, Angel Pang, et al.
The Journal of Rheumatology
|
January 15, 2025
Association Between Abatacept Exposure Levels and Infection Occurrence in Patients With Rheumatoid Arthritis: Post Hoc Analysis of the AVERT-2 Study
Paul Emery, Roy Fleischmann, Robert Wong, et al.
Clinical Pharmacology and Therapeutics
|
June 24, 2025
Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart Disease
Antoinette Ajavon-Hartmann, Praneeth Jarugula, Hyunmoon Back, et al.
British Journal of Clinical Pharmacology
|
January 19, 2018
First-in-human study to assess the safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects
Vidya Perera, Joseph M Luettgen, Zhaoqing Wang, et al.
Page
of 5